|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: RANEXA
Summary for Tradename: RANEXA
|
| Pharmacology for Tradename: RANEXA
| ||||||||||
Clinical Trials for: RANEXARanolazine in Atrial Fibrillation Following An ELectricaL CardiOversion Status: Active, not recruiting Condition: Persistent Atrial Fibrillation A Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation (HARMONY) Status: Recruiting Condition: Atrial Fibrillation Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients Status: Completed Condition: End-stage Renal Disease; Cardiovascular Disease Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine Status: Completed Condition: Type 2 Diabetes Mellitus Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Status: Completed Condition: Type 2 Diabetes Mellitus Ranolazine in Ischemic Cardiomyopathy Patients With Persistent Chest Pain or Dyspnea Despite Conventional Therapy: A Cross-Over Study Status: Recruiting Condition: Cardiomyopathy; Chest Pain; Dyspnea The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC) Status: Recruiting Condition: Cardiomyopathy Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia Status: Not yet recruiting Condition: Coronary Artery Disease; Acute Myocardial Ischemia Safety of Amiodarone and Ranolazine Together in Patients With Angina Status: Recruiting Condition: Chronic Stable Angina; Coronary Artery Disease; Atrial Fibrillation; Ventricular Tachycardia An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041) Status: Completed Condition: Chronic Angina Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilead | RANEXA | ranolazine | TABLET, EXTENDED RELEASE; ORAL | 021526 | Feb 12, 2007 | RX | Yes | 6,303,607 | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gilead | RANEXA | ranolazine | TABLET, EXTENDED RELEASE; ORAL | 021526 | Feb 12, 2007 | RX | Yes | 6,369,062 | Y | Y | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gilead | RANEXA | ranolazine | TABLET, EXTENDED RELEASE; ORAL | 021526 | Feb 12, 2007 | RX | Yes | 6,479,496 | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gilead | RANEXA | ranolazine | TABLET, EXTENDED RELEASE; ORAL | 021526 | Feb 12, 2007 | RX | Yes | 6,503,911 | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc
